Effectiveness of an Acupressure Band for Primary Dysmenorrhea in College Students

NCT07794995 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-31

No results posted yet for this study

Summary

This study aims to investigate the effectiveness of an acupressure band in improving primary dysmenorrhea among college students. Primary dysmenorrhea is characterized by cramping lower abdominal pain during menstruation and is often accompanied by symptoms such as nausea, fatigue, and headache. It is also one of the leading causes of academic and work absenteeism among women of reproductive age. Previous studies have shown that acupressure applied to the Sanyinjiao (SP6) acupoint can alleviate menstrual pain. In addition, current clinical research has mainly focused on auricular acupressure using Vaccaria seeds, while relatively few studies have explored their application on body acupoints. Therefore, this study focuses on the application of Vaccaria seeds on the Sanyinjiao (SP6) acupoint to evaluate their effects on primary dysmenorrhea.

To provide continuous and stable acupoint stimulation, this study utilizes an intervention device combining Vaccaria seeds with a compression band, together with acupressure stimulation.

This study adopts a single-blind randomized controlled trial design. A total of 30 participants will be randomly assigned to either the experimental group or the control group (compression band only group). The study consists of four menstrual cycles, including one baseline menstrual cycle followed by three consecutive menstrual cycles of home-based intervention.

Outcome measures include the Visual Analog Scale (VAS) for pain intensity, the Menstrual Distress Questionnaire (MEDI-Q) for menstrual-related symptoms and distress, and heart rate variability (HRV), monitored using the ANS Watch as an indicator of autonomic nervous system activity. Statistical analyses will be conducted to compare differences between the experimental and control groups, as well as between pre- and post-intervention measurements, in order to evaluate the clinical potential of the acupressure band for primary dysmenorrhea management.

Conditions

  • Primary Dysmenorrhea (PD)

Interventions

DEVICE

Compression band with vaccaria seeds

The intervention utilizes an adjustable band with three Vaccaria seeds forming a 5 mm circular stimulation area, designed to cover the Sanyinjiao (SP6) acupoint region. The seeds are fixed on the inner side of the band. In the first session, a medical student research assistant trained in acupuncture will teach the participant how to locate the SP6 acupoint (3 cun or 4 finger-widths above the tip of the medial malleolus, at the posterior border of the tibia). For subsequent home-based intervention, participants will locate and apply the band by themselves. The band consists of 60% non-elastic and 40% elastic materials with a 3 cm velcro buffer.

DEVICE

Compression band only

The control group utilizes the same adjustable band design but without any Vaccaria seeds on the inner side. In the first session, a medical student research assistant will guide the participant to locate the Sanyinjiao (SP6) region on the calf for standardization. Participants will wear and apply the band by themselves at home following the same instructions. The band consists of 60% non-elastic and 40% elastic materials, with a 3-cm Velcro buffer.

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV
  • China Medical University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
24 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07794995 on ClinicalTrials.gov